Jessica K. Altman

James M. Foran, MD, FRCPC, Jessica K. Altman, MD - The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes

James M. Foran, MD, FRCPC, Jessica K. Altman, MD - The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes

James M. Foran, MD, FRCPC, Jessica K. Altman, MD - The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes

James M. Foran, MD, FRCPC, Jessica K. Altman, MD - The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes

James M. Foran, MD, FRCPC, Jessica K. Altman, MD - The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes

James M. Foran, MD, FRCPC, Jessica K. Altman, MD - The Convergence of Innovative Therapy and AlloHCT in AML: Applying Current Evidence to Improve Outcomes

The Regulators S3 E7: A Conversation About Long-Term Care Insurance with Pennsylvania Insurance Commissioner Jessica K. Altman and Virginia

Episode 6 - Myeloid Malignancies Update - Joseph R. Mikhael, MD and Jessica K. Altman, MD

Episode 6 - Myeloid Malignancies Update - Joseph R. Mikhael, MD and Jessica K. Altman, MD

Episode 4 - Effective Management and Patient Experience from Seattle to Chicago - Joseph R. Mikhael, MD; Jessica K. Altman, MD; Michael Angarone, DO; Yelak Biru; Matthew R. Levine, MD; Mary-Beth Percival, MD